Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal
1. Zenrelia shows improved clinical outcomes compared to Apoquel in new study.
FAQ
Why Bullish?
Positive study results for Zenrelia may enhance its market position and sales, similar to past drug success stories.
How important is it?
The study's findings can significantly influence Zenrelia's adoption and sales, impacting ELAN's financial performance.
Why Long Term?
Sustained improvement in clinical outcomes could lead to stronger future revenues as adoption increases.